AGXTCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。AGXT遺伝子サイレンサーは、AGXT CRISPR/Cas9ノックアウトプラスミドとAGXTDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のAGXTCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
AGXT CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
AGXT CRISPR/Cas9 KOプラスミド (h) | sc-407697 | h | Gene Knockout | GFP | 0 | ||
AGXT HDRプラスミド (h) | sc-407697-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
AGXT Double Nickaseプラスミド (h) | sc-407697-NIC | h | Gene Knockout | Puromycin | 0 | ||
AGXT Double Nickaseプラスミド (h2) | sc-407697-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
AGXT CRISPR/Cas9 KOプラスミド (m) | sc-419052 | m | Gene Knockout | GFP | 0 | ||
AGXT CRISPR/Cas9 KOプラスミド (m2) | sc-419052-KO-2 | m | Gene Knockout | GFP | 0 | ||
AGXT Double Nickaseプラスミド (m) | sc-419052-NIC | m | Gene Knockout | Puromycin | 0 | ||
AGXT Double Nickaseプラスミド (m2) | sc-419052-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
AGXT2 CRISPR/Cas9 KOプラスミド (h) | sc-413054 | h | Gene Knockout | GFP | 0 | ||
AGXT2 HDRプラスミド (h) | sc-413054-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
AGXT2 Double Nickaseプラスミド (h) | sc-413054-NIC | h | Gene Knockout | Puromycin | 0 | ||
AGXT2 Double Nickaseプラスミド (h2) | sc-413054-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
AGXT2 CRISPR/Cas9 KOプラスミド (m) | sc-435279 | m | Gene Knockout | GFP | 0 | ||
AGXT2 HDRプラスミド (m) | sc-435279-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
AGXT2 Double Nickaseプラスミド (m) | sc-435279-NIC | m | Gene Knockout | Puromycin | 0 | ||
AGXT2 Double Nickaseプラスミド (m2) | sc-435279-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
AGXT2L1 CRISPR/Cas9 KOプラスミド (h) | sc-409317 | h | Gene Knockout | GFP | 0 | ||
AGXT2L1 HDRプラスミド (h) | sc-409317-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
AGXT2L1 Double Nickaseプラスミド (h) | sc-409317-NIC | h | Gene Knockout | Puromycin | 0 | ||
AGXT2L1 Double Nickaseプラスミド (h2) | sc-409317-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
AGXT2L2 CRISPR/Cas9 KOプラスミド (h) | sc-413758 | h | Gene Knockout | GFP | 0 | ||
AGXT2L2 HDRプラスミド (h) | sc-413758-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
AGXT2L2 Double Nickaseプラスミド (h) | sc-413758-NIC | h | Gene Knockout | Puromycin | 0 | ||
AGXT2L2 Double Nickaseプラスミド (h2) | sc-413758-NIC-2 | h | Gene Knockout | Puromycin | 0 |
AGXT CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
AGXT CRISPR Activationプラスミド (h) | sc-407697-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT CRISPR Activationプラスミド (h2) | sc-407697-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT Lentiviral Activation Particles (h) | sc-407697-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT Lentiviral Activation Particles (h2) | sc-407697-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT CRISPR Activationプラスミド (m) | sc-419052-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT CRISPR Activationプラスミド (m2) | sc-419052-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT Lentiviral Activation Particles (m) | sc-419052-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT Lentiviral Activation Particles (m2) | sc-419052-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2 CRISPR Activationプラスミド (h) | sc-413054-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2 CRISPR Activationプラスミド (h2) | sc-413054-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2 Lentiviral Activation Particles (h) | sc-413054-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2 Lentiviral Activation Particles (h2) | sc-413054-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2 CRISPR Activationプラスミド (m) | sc-435279-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2 CRISPR Activationプラスミド (m2) | sc-435279-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2 Lentiviral Activation Particles (m) | sc-435279-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2 Lentiviral Activation Particles (m2) | sc-435279-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2L1 CRISPR Activationプラスミド (h) | sc-409317-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2L1 CRISPR Activationプラスミド (h2) | sc-409317-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2L1 Lentiviral Activation Particles (h) | sc-409317-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2L1 Lentiviral Activation Particles (h2) | sc-409317-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2L2 CRISPR Activationプラスミド (h) | sc-413758-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2L2 CRISPR Activationプラスミド (h2) | sc-413758-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2L2 Lentiviral Activation Particles (h) | sc-413758-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
AGXT2L2 Lentiviral Activation Particles (h2) | sc-413758-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 |